These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12199673)

  • 41. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
    Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
    Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune Responses to Plasma-Derived Versus Recombinant FVIII Products.
    Peyvandi F; Miri S; Garagiola I
    Front Immunol; 2020; 11():591878. PubMed ID: 33552050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factor VIII inhibitors: a 50-year perspective.
    Green D
    Haemophilia; 2011 Nov; 17(6):831-8. PubMed ID: 21592257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW; Chen LS; Jayakodi D; Dunkley SM
    Thromb Res; 2013; 132(6):735-41. PubMed ID: 24119613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
    Pezeshkpoor B; Berkemeier AC; Herbst K; Albert T; Müller J; Oldenburg J
    J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
    Astermark J; Voorberg J; Lenk H; DiMichele D; Shapiro A; Tjönnfjord G; Berntorp E
    Haemophilia; 2003 Sep; 9(5):567-72. PubMed ID: 14511295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibitors: our greatest challenge. Can we minimize the incidence?
    Kruse-Jarres R
    Haemophilia; 2013 Jan; 19 Suppl 1():2-7. PubMed ID: 23278993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates.
    Zanon E; Zerbinati P; Girolami B; Bertomoro A; Girolami A
    Blood Coagul Fibrinolysis; 1999 Apr; 10(3):117-20. PubMed ID: 10357004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biomimetic biosensor to distinguish between inhibitory and non-inhibitory factor VIII antibodies.
    Kocot C; Schindler AR; Le Blanc A; Schmalenberg M; Miesbach W; Spannagl M; Luppa PB
    Anal Bioanal Chem; 2015 Jul; 407(19):5685-93. PubMed ID: 25957847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of lupus anticoagulants in immediate acting inhibitor positivity in congenital haemophilia A patients.
    Patil R; S C; Parihar A; Mohite A; Shetty S
    Thromb Res; 2018 Dec; 172():29-35. PubMed ID: 30359788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A.
    Furlong RA; Chesham J; Peake IR
    Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
    Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH; Kelley L; Green D
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetics of the interaction between anti-FVIII antibodies and FVIII from therapeutic concentrates, with and without von Willebrand factor, assessed by surface plasmon resonance.
    Grancha S; Ortiz AM; Marañón C; Hampel K; Moret A; Zimmermann B; Jorquera JI; Aznar JA
    Haemophilia; 2012 Nov; 18(6):982-9. PubMed ID: 22646163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitors in haemophilia A: the role of VWF/FVIII concentrates--a meeting report.
    Kaveri S; Gringeri A; Heisel-Kurth M; Kreuz W
    Haemophilia; 2009 Mar; 15(2):587-91. PubMed ID: 19347997
    [No Abstract]   [Full Text] [Related]  

  • 58. ELISA for factor VIII antibodies: does it detect antibodies much before the conventional Bethesda assay?
    Shetty S; Ghosh K; Mohanty D
    Haemophilia; 2003 Sep; 9(5):654. PubMed ID: 14511311
    [No Abstract]   [Full Text] [Related]  

  • 59. [Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A].
    Fan LK; Wang ZW; Hua BL; Su W; Wang SJ; Zhao YQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):551-4. PubMed ID: 19968068
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
    Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
    Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.